The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released its disclosure code of “transfers of value” (payments, hospitality, etc) to health care professionals and organizations. The code requires all members of the EFPIA to disclose transfers of value to professionals and pharma companies (HCO)’s as of 2016 regarding all transfers in 2015.
The EFPIA says it is committed to introducing greater transparency around industry’s interactions with HCP’s and HCO’s, stating: “Our industry’s collaboration with health care professionals requires a well-regulated, ongoing scientific dialogue in both directions. This is fundamental to ensuring a positive working relationship that best serves the interests of patients. Collaborations and partnerships between HCP's and industry are subject to stringent legislation and require that all parties respect high ethical standards. EFPIA’s code will enhance transparency around these relationships, and ensure that the industry’s work with HCP's and HCO's is well understood by the public and health care stakeholders.
“Demonstrates commitment to transparency”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze